Doctor profile · Federal record
Dr. Mark Manning, DNP
Nurse Practitioner · Family Nurse Practitioner · West Lafayette, IN
- NPI 1699171215
- Accepts Medicare
- MIPS 87.8 / 100 · 2023
- 12 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
124 Sagamore Pkwy West
West Lafayette, IN 47906
(765) 463-6722
fax (765) 463-0905
Credentials & registration
- NPI registered
- November 2014 — 12 yrs on file
- Profile last updated
- June 2, 2025
- Year of graduation
- 2014 — 12 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State licenses (2)
- Indiana #71006259A · Washington #AP60520310
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1699171215. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,199
Distinct HCPCS
10
Medicare allowed
$68,295
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 437 | 60 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 197 | 141 | $72 | |
17110 |
Destruction of skin growth, 1-14 growths | 133 | 95 | $89 | |
17000 |
Destruction of precancer skin growth, 1 growth | 125 | 86 | $39 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 74 | 62 | $45 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 48 | 32 | $103 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 44 | 44 | $90 | |
J7308 |
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 30 | 19 | $385 | |
11102 |
Biopsy of related skin growth, first growth | 27 | 27 | $69 | |
96567 |
Application of light to destroy precancer skin growth | 25 | 18 | $111 |
In context: peer comparison
Among 6 peers in this city , average services per provider: 106. This provider delivers 11× the peer median.Open Payments
Industry payments received
All-time total
$1,317
Transactions
86
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 28 | $235.50 | |
| Janssen Biotech, Inc. | 12 | $210.17 | |
| E.R. Squibb & Sons, L.L.C. | 9 | $170.37 | |
| ABBVIE INC. | 13 | $135.99 | |
| Regeneron Healthcare Solutions, Inc. | 4 | $116.06 | |
| Incyte Corporation | 4 | $85.63 | |
| Lilly USA, LLC | 4 | $82.85 | |
| GENZYME CORPORATION | 3 | $82.45 | |
| UCB, Inc. | 3 | $71.96 | |
| Kerecis Limited | 1 | $39.30 | |
| PFIZER INC. | 2 | $38.47 | |
| Dermavant Sciences, Inc. | 2 | $34.95 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $13.75 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
236
Patients
93
Total drug cost
$7,213
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 124 | 55 | $4,015 |
| Triamcinolone Acetonide | Generic | 34 | 26 | $308 |
| Doxycycline Monohydrate | Generic | 23 | 0 | $724 |
| Metronidazole | Generic | 16 | 0 | $1,548 |
| Betamethasone Valerate | Generic | 14 | 0 | $439 |
| Cephalexin | Generic | 13 | 12 | $121 |
| Hydrocortisone | Generic | 12 | 0 | $58 |
Frequently asked questions
What is Dr. Mark Manning's medical specialty?
Dr. Mark Manning practices Nurse Practitioner in West Lafayette, IN.
Where does Dr. Mark Manning practice?
Dr. Mark Manning practices at 124 Sagamore Pkwy West, West Lafayette, IN 47906. Office phone: 7654636722.
What is Dr. Mark Manning's NPI?
Dr. Mark Manning's National Provider Identifier (NPI) is 1699171215, issued by NPPES.
Does Dr. Mark Manning accept Medicare assignment?
Yes. Dr. Mark Manning accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Manning commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of skin growth, 1-14 growths (HCPCS 17110). Source: CMS Medicare Physician & Other Practitioners file.